Industry responds to call to roll out coronavirus tests
The UK’s top pharmaceutical and diagnostic companies are teaming up to rapidly develop and roll out millions of coronavirus tests in the coming months...
Private hospital merger to be approved if local concerns addressed
The CMA has found that the completed private hospital merger between Circle and BMI does not raise UK-wide competition concerns but could reduce competition...
Cancer Research UK to cut funding by £44m
Cancer Research UK has announced that it has taken the difficult decision to cut funding to its existing grants and institutes by up to...
New vaccine platform used to develop COVID-19 vaccine candidates
UK biotech Imophoron has produced multiple COVID-19 vaccine candidates, based on its novel vaccine platform (ADDomer©), within weeks of the virus sequence being made...
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
NICE COVID-19 guidelines: severe asthma, pneumonia, rheumatological disorders, symptom management
New NICE COVID-19 guidelines have been published on severe asthma, pneumonia, rheumatological disorders and symptom management in community settings. NICE has published the four new...
Life sciences industry releases COVID-19 testing and diagnostics FAQs
The life sciences industry released a joint statement on COVID-19 testing and diagnostics along with useful COVID-19 testing and diagnostics FAQs. The FAQs have been...
Life sciences’ COVID-19 testing and diagnostics statement
The life sciences industry has released a joint statement on COVID-19 testing and diagnostics as the Government confirms that testing capacity will increase. The statement...
Rapid COVID-19 diagnostic test to be deployed in hospitals
A new rapid COVID-19 diagnostic test developed by a University of Cambridge spinout company and capable of diagnosing the infection in under 90 minutes,...
Interim analysis data for Siltuximab-Treated COVID-19 Patients study
An update on the Siltuximab clinical study brings interim analysis data for Siltuximab-Treated COVID-19. EUSA Pharma has announced the initial preliminary findings from the Papa...
Latest articles
Partnership announced to fight against counterfeit drugs
Advanco and Syntegon have announced a strategic partnership, marking a significant step towards helping to eradicate the growing problem of counterfeit drugs. The counterfeit...
GSK receives CHMP positive opinion for Zejula▼(niraparib)
GSK receives CHMP positive opinion recommending approval of Zejula▼(niraparib) as first-line monotherapy maintenance treatment for women with platinum-responsive advanced ovarian cancer. GlaxoSmithKline (GSK) plc announced...
WAYLIVRA▼® (volanesorsen) for FCS to be available on the NHS in England
The National Institute for Health and Care Excellence (NICE) has issued a positive recommendation for WAYLIVRA▼® (volanesorsen), the first and only therapy for adults...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Rapid COVID-19 diagnostic test to be deployed in hospitals
A new rapid COVID-19 diagnostic test developed by a University of Cambridge spinout company and capable of diagnosing the infection in under 90 minutes,...
GSK receives CHMP positive opinion for Zejula▼(niraparib)
GSK receives CHMP positive opinion recommending approval of Zejula▼(niraparib) as first-line monotherapy maintenance treatment for women with platinum-responsive advanced ovarian cancer. GlaxoSmithKline (GSK) plc announced...
Understanding the role of the MSL
Helen Kane surveyed more than 200 medical science liaisons (MSLs) to understand more about their current in-role reality. She gave Pf Magazine exclusive access...
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...